High sugar intake via the renin-angiotensin system blunts the baroreceptor reflex in adult rats that were perinatally depleted of taurine.
Perinatal taurine depletion leads to several physiological impairments in adult life, in part, due to taurine's effects on the renin-angiotensin system, a crucial regulator of growth and differentiation during early life. The present study tests the hypothesis that perinatal taurine depletion predisposes adult female rats to impaired baroreceptor control of arterial pressure by altering the renin-angiotensin system. Female Sprague Dawley (SD) rats were fed normal rat chow and from conception to weaning drank 3% beta-alanine in water (taurine depletion, TD) or water alone (Control, C). Female offspring ate a normal rat chow and drank water with (G) or without (W) 5% glucose throughout the experiment. To test the possible role of the renin-angiotensin system, 50% of the rats received captopril (an angiotensin converting enzyme inhibitor, 400 mg/L) from 7 days before parameter measurements until the end of experiment. At 7-8 weeks of age, arterial pressure, heart rate, baroreflex control of heart rate and renal nerve activity were studied in either conscious, freely moving or anesthetized rats. Perinatal taurine depletion did not alter resting mean arterial pressure or heart rate in the adult female offspring that received either high or normal sugar intake. Captopril treatment slightly decreased mean arterial pressure but not heart rate in all groups. Compared to controls, only the TDG rats displayed blunted baroreflex responses. Captopril treatment normalized baroreflex sensitivity in TDG. The present data indicate that in perinatal taurine depleted female rats, the renin-angiotensin system underlines the ability of high sugar intake to blunt baroreceptor responses.
Thaeomor
Atcharaporn
A
Department of Physiology Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. thawmor@yahoo.com
Wyss
J Michael
JM
Jirakulsomchok
Dusit
D
Roysommuti
Sanya
S
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D017704:Baroreflex / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000494:pharmacology; D005260:Female; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D010656:Phenylephrine / Q000494:pharmacology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D013654:Taurine / Q000172:deficiency*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000806:Angiotensin-Converting Enzyme Inhibitors; D014662:Vasoconstrictor Agents; D013654:Taurine; D010656:Phenylephrine; D002216:Captopril; D005947:Glucose
Am J Physiol Renal Physiol. 2000 Jan;278(1):F122-9
10644663
J Am Soc Nephrol. 1999 Jul;10(7):1550-60
10405211
Hypertension. 1994 Jun;23(6 Pt 1):791-6
8206579
Brain Res Bull. 1998;45(2):189-97
9443839
Acta Physiol Scand. 1999 Jan;165(1):103-12
10072103
Amino Acids. 2000;19(3-4):499-507
11140355
Am J Hypertens. 2002 Sep;15(9):773-9
12219871
Regul Pept. 2008 Feb 7;146(1-3):38-45
17822786
Mol Cell Biochem. 2009 Dec;332(1-2):145-59
19536638
Diabetologia. 2004 Feb;47(2):240-8
14722647
Diabetologia. 1984 Sep;27(3):351-7
6389240
Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1083-9
17449556
Heart Vessels. 2004 May;19(3):132-6
15168061
Int J Epidemiol. 2002 Dec;31(6):1235-9
12540728
Mol Cell Endocrinol. 2009 Apr 29;302(2):128-39
19150387
Neuroendocrinology. 2009;89(4):361-9
19174604
Can J Physiol Pharmacol. 2004 Jan;82(1):1-8
15052299
Adv Exp Med Biol. 2009;643:135-44
19239144
Amino Acids. 2000;18(4):305-18
10949914
Clin Endocrinol (Oxf). 2009 Jul;71(1):1-6
19138313
Adv Exp Med Biol. 2009;643:145-56
19239145
Clin Biochem. 2009 Sep;42(13-14):1331-46
19501581
Diabetes. 2006 Feb;55(2):367-74
16443769
Exp Neurol. 2009 Dec;220(2):246-54
19682991
J Hypertens. 1995 Sep;13(9):1037-42
8586822
J Perinat Med. 2002;30(4):281-6
12235714
Eur J Pharmacol. 2000 Sep 8;403(3):181-8
10973617
Physiol Rev. 1993 Jan;73(1):119-47
8419963
Diabetes Metab Res Rev. 2009 May;25(4):370-9
19405082
Adv Exp Med Biol. 2009;643:353-8
19239166
Pflugers Arch. 2006 Feb;451(5):668-77
16249932
J Physiol. 2007 Apr 1;580(Pt 1):31-7
17218353
Ann N Y Acad Sci. 2001 Jun;940:395-406
11458695
Adv Exp Med Biol. 2009;643:123-33
19239143
J Am Coll Nutr. 1994 Feb;13(1):73-82
8157859
Hypertension. 2008 Feb;51(2):514-20
18158342
Hypertension. 2004 Jul;44(1):83-8
15184350
Am J Physiol. 1994 Feb;266(2 Pt 2):R481-6
8141406